{
    "clinical_study": {
        "@rank": "18298", 
        "brief_summary": {
            "textblock": "This pilot study will explore if continuation of treatment of treatment with Aczone 5% gel\n      following combination treatment with with doxycycline and Aczone 5% gel can maintain\n      therapeutic response."
        }, 
        "brief_title": "Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acne Vulgaris", 
        "condition_browse": {
            "mesh_term": "Acne Vulgaris"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Outpatient, male or female subjects of any race, age 12 or older.  Female subjects of\n             childbearing potential must have a negative urine pregnancy test result at Baseline\n             and practice a reliable method of contraception throughout the study;\n\n          -  Facial acne vulgaris characterized by the following:\n\n        IGA Score >3 10-50 facial inflammatory lesions (papules,pustules) 10-100 facial\n        non-inflammatory lesions (open/closed comedones)\n\n          -  Able to understand and comply with the requirements of the study and sign Informed\n             Consent/HIPAA Authorization forms\n\n        Exclusion Criteria:\n\n          -  Female subjects who are pregnant (positive urine pregnancy test), breast feeding, or\n             who are of childbearing potential and not practicing a reliable method of birth\n             control.\n\n          -  Allergy/sensitivity to any component of the test treatment (Section 5.2), lincomycin,\n             tetracyclines, or sulfites.\n\n          -  Subjects who have not complied with the proper wash-out periods for prohibited\n             medications/procedures (Supplement 1)>\n\n          -  History of clinically significant anemia or hemolysis.\n\n          -  History of enteritis (regional enteritis, ulcerative colitis, pseudomembranous\n             colitis, or antibiotic-associated colitis).\n\n          -  Skin disease/disorder that might interfere with the diagnosis or evaluation of acne\n             vulgaris\n\n          -  Evidence of recent alcohol or drug abuse\n\n          -  Medical condition that, in the opinion of the Investigator, contraindicates the\n             subject's participation in the clinical study\n\n          -  History of poor cooperation, non-compliance with medical treatment or unreliability\n\n          -  Participation in an investigational drug study within 30 days of the baseline visit."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885910", 
            "org_study_id": "IIT-000508"
        }, 
        "intervention": {
            "description": "Subject is to take Doxycycline 100mg by mouth once daily and apply Aczone 5% gel to their face twice daily for 12 weeks; those subjects achieving treatment response will stop Doxycycline and continue applying Aczone 5% gel twice daily for 12 more weeks.", 
            "intervention_name": "Doxycycline 100mg and Aczone 5% gel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dapsone", 
                "Doxycycline", 
                "Doxycycline hyclate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 16, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Louisville", 
                    "country": "United States", 
                    "state": "Kentucky", 
                    "zip": "40217"
                }, 
                "name": "DermResearch, PLLC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Investigator Global Assessment (IGA) of acne vulgaris", 
            "safety_issue": "No", 
            "time_frame": "Every 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885910"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Inflammatory and non-inflammatory lesion counts", 
            "safety_issue": "No", 
            "time_frame": "Every 4 weeks"
        }, 
        "source": "Derm Research, PLLC", 
        "sponsors": {
            "collaborator": {
                "agency": "WFH MEDICAL, LLC", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Derm Research, PLLC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}